Max Planck Institute for Synthetic Biology

pursuing bottom-up synthetic biology, including minimal approaches to synthetic cell construction and the design of photosynthetic synthetic organisms.

Country: Germany

research eu

Coverage

	CN	EU	US
bioinformatics-omics	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Affiliation	Max Planck Research Network in Synthetic Biology (MaxSynBio)	maxsynbio.mpg.de
Research focus	bottom-up synthetic biology, including minimal synthetic cell construction and synthetic metabolism/photosynthesis	pubmed.ncbi.nlm.nih.gov · maxsynbio.mpg.de
Facility	Microfluidic Systems Facility (Göttingen), Facility for Cell-Free Protein Expression (Martinsried), and Dortmund Protein Facility	maxsynbio.mpg.de
Grant	Funded by Max Planck Society (MPG) and Federal Ministry of Education and Research (BMBF)	maxsynbio.mpg.de · mpi-magdeburg.mpg.de
Headcount	Approximately 50 principal investigators, postdocs, PhD students, and technicians	maxsynbio.mpg.de
Principal staff	Kai Sundmacher (chief coordinator), Petra Schwille (chief coordinator), Jakob Schweizer (scientific coordinator), Tobias Erb, Dora Tang, Rumiana Dimova, Tom Robinson, and others	pubmed.ncbi.nlm.nih.gov · maxsynbio.mpg.de

Independent sources: maxsynbio.mpg.de · mpi-magdeburg.mpg.de · pubmed.ncbi.nlm.nih.gov

Technologies

Name	Cluster	Risk
Genomics & DNA design	bioinformatics-omics	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.